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Hyperlipidemia is deﬁned as the presence of either hypertriglyceridemia or hypercholesterolemia, which
could cause atherosclerosis. Although hyperlipidemia can be treated by hypolipidemic drugs, they are
limited due to lack of effectiveness and safety. Previous studies demonstrated that xanthorrhizol (XNT)
isolated from Curcuma xanthorrhizza Roxb. reduced the levels of free fatty acid and triglyceride in vivo.
However, its ability to inhibit cholesterol uptake in HT29 colon cells and adipogenesis in 3T3-L1 cells are
yet to be reported. In this study, XNT puriﬁed from centrifugal TLC demonstrated 98.3% purity, indicating
it could be an alternative puriﬁcation method. The IC50 values of XNT were 30.81 ± 0.78 mg/mL in
HT29 cells and 35.07 ± 0.24 mg/mL in 3T3-L1 adipocytes, respectively. Cholesterol uptake inhibition study
using HT29 colon cells showed that XNT (15 mg/mL) signiﬁcantly inhibited the ﬂuorescent cholesterol
analogue NBD uptake by up to 27 ± 3.1% relative to control. On the other hand, higher concentration of
XNT (50 mg/mL) signiﬁcantly suppressed the growth of 3T3-L1 adipocytes (5.9 ± 0.58%) compared to 3T3-
L1 preadipocytes (81.31 ± 0.55%). XNT was found to impede adipogenesis of 3T3-L1 adipocytes in a dose-
dependent manner from 3.125 to 12.5 mg/mL, where 12.5 mg/mL signiﬁcantly suppressed 36.13 ± 2.1% of
lipid accumulation. We postulate that inhibition of cholesterol uptake, adipogenesis, preadipocyte and
adipocyte number may be utilized as treatment modalities to reduce the prevalence of lipidemia. To
conclude, XNT could be a potential hypolipidemic agent to improve cardiovascular health in the future.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hyperlipidemia is the conditionwhereby any or all lipids and/or
lipoproteins are abnormally elevated in the blood [1]. The plasma
hyperlipidemic state could cause atherosclerosis and cardiovascu-
lar diseases [2]. Seeing that abnormal lipid metabolism is known to
cause obesity [1], World Health Organization (WHO) reported at
least 2.8 million people dying every year due to overweight or
obesity [3]. In fact, body fat mass and cholesterol turnover are
closely related to each other in lipid metabolism [4]. It has been
reported that obesity stimulated cholesterol synthesis and weight), meenakshii@upm.edu.my
m), shamarina@upm.edu.my
jaya), thiamtsu@zachbio.com
Inc. This is an open access article ureduction successfully attenuated cholesterol level [5]. Therefore,
bioactive compound which exerts effective reduction of body
weight may attenuate high cholesterol production in obesity.
Although many drugs have shown to reduce body fat and circu-
lating cholesterol levels, they have severe side effects [6,7]. For
example, cholesterol-lowering drugs such as resins and statins can
induce constipation and muscle inﬂammation respectively [8].
Also, several anti-obesity drugs have been stopped by Food and
Drug Administration (FDA) from clinical use due to complications
associated to depression and cardiovascular side effects [7].
These circumstances have increased demand for effective and
safe hypolipidemic agents [9]. Increasing research in natural
products showed that phytosterols such as diosgenin, campesterol,
sitosterol, stigmasterol and brassicasterol exhibited hypo-
cholesterolemic effect, mainly through the reduction of intestinal
cholesterol absorption [4,9]. Also, dietary supplements of resvera-
trol, vitamin D, quercetin, and genistein have been reported tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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by increased adipocyte number and size that causes the adipose
tissue to expand, which is also accompanied by imbalance energy
input and output [11,12]. Thus, the fat mass may be suppressed by
inhibiting adipogenesis, lipid accumulation and the number of
preadipocytes and adipocytes [13].
In Malaysia, one of the local herbs namely Curcuma xanthor-
rhizza, is believed to have anti-hyperlipidemic bioactive component
known as xanthorrhizol (XNT). Previous studies demonstrated that
XNT reduced the serum levels of free fatty acid and triglyceride in
high-fat diet-(HFD)-induced obese mice [14]. It has also been
shown to promote cardiovascular health through anti-
hyperglycemic [14], vasorelaxation [15] and LDL oxidation inhibi-
tory effects [16]. However, inhibitory activities of cholesterol uptake
and differentiation of preadipocytes have not yet been elucidated.
Our recent review [17] indicated that there are little scientiﬁc
studies being conducted on anti-hyperlipidemic activities of XNT.
In addition, isolation of highly pure XNT is tedious. A better
option is needed to accelerate the isolation process. One of the
challenges in optimizing the best puriﬁcation method is trial-and-
error approach. Various techniques have been used for isolation of
XNT, but the puriﬁcation of XNT employing centrifugal thin layer
chromatography (TLC) is yet to be reported. Since our previous
isolation demonstrated a low yield of pure XNT, we would like to
determine if centrifugal TLC would be an alternative puriﬁcation
method. The objectives of this study focused on the biological ac-
tivities of XNT puriﬁed from centrifugal TLC on the inhibition of
cholesterol uptake by HT29 colon cells, suppression of 3T3-L1
preadipocyte differentiation and its antiproliferative activities.
2. Materials and methods
2.1. Puriﬁcation of XNT by centrifugal TLC
Crude XNT was obtained from grounded rhizomes of
C. xanthorrhizza Roxb. by supercritical ﬂuid carbon dioxide extrac-
tion (Taiwan Supercritical Technology Co., Ltd) [18]. The fractions
containing XNT were subjected to centrifugal TLC, as performed by
Chromatotron 7924T (T-Squared Technology, USA). The sorbent
(1 mm) was prepared using silica gel TLC standard grade with
254 nm ﬂuorescent indicator and gypsum. The fraction was eluted
with hexane with gradual increase ratio of chloroform to get pu-
riﬁed XNT. Concentric spherical bands of the separated compounds
were monitored by UV 254/365 lamps on the rotor. As each single
band came to the edge of the rotor, the eluatewas collected. Eluates
containing XNT as a single spot in TLC were pooled together and
dried under rotary evaporator.
2.2. Identiﬁcation of XNT
The purity of XNTwas determined by gas chromatography-mass
spectrometry (GC-MS) on Shimadzu GCMS-QP2010 Plus and
analyzed by GCMSsolution software [19]. The compound was
identiﬁed by direct comparison of the electron ionization (EI) mass
spectral result, such as the total ion chromatogram (TIC) in GC-MS
proﬁle with National Institute of Standards and Technology (NIST)
08s mass spectral library. Then, the structure of XNTwas conﬁrmed
by 1H and 13C nuclear magnetic resonance (NMR) spectral analysis.
2.3. HT29 and 3T3-L1 cell culture
HT29 human colon adenocarcinoma cells and 3T3-L1 mouse
embryonic ﬁbroblasts were obtained from American Type Culture
Collection (ATCC® CL-173™, Rockville, MD, USA). They were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM; Gibco,CA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco,
CA, USA). They were maintained in a humidiﬁed atmosphere of 5%
CO2 in air at 37 C and kept in the logarithmic growth phase.
2.4. Differentiation of 3T3-L1 cells
3T3-L1 preadipocytes were differentiated with slight modiﬁca-
tion [20,21]. Brieﬂy, 3T3-L1 preadipocytes were cultured in DMEM
containing 10% FBS until conﬂuent [21]. Two days after 100%
conﬂuent, the cells were further incubated with fresh medium.
After 72 h, the medium was replaced with differentiation medium
containing 90% DMEM, 10% FBS (Invitrogen), 0.5 mM iso-
butylmethylxanthine (Sigma-Aldrich), 1.0 mM dexamethasone
(Sigma-Aldrich) and 1.0 mg/mL insulin (Sigma-Aldrich) and desig-
nated as day 0. On day 3, the differentiation medium was gently
removed and replaced with adipocyte maintenance medium (10%
FBS/DMEM containing 1.0 mg/mL insulin) and incubated for another
three days. Maintenance medium was changed every three day
until the cells were completely differentiated at day 15.
2.5. Cell proliferation assay
HT29 colon cells (10,000 cells/well) and 3T3-L1 cells (8000 cells/
well) were seeded overnight prior to treatment in 96-well plates.
XNT was dissolved in DMSO, where the ﬁnal concentration of
DMSO did not exceed 0.1% (v/v). HT29 colon cells, 3T3-L1 pre-
adipocytes and adipocytes were incubated with 1.563, 3.125, 6.25,
12.5, 25 and 50 mg/mL XNT for 48 h. Cells incubated in complete
culture medium containing 0.1% DMSOwithout XNTwere used as a
control. At the end of incubation, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetraolium bromide (MTT) assay was done as previously
described [10,18]. Percentage of growth was calculated as: (Ti/
Tc)  100 where Tc is control growth and Ti is test growth in the
presence of XNT at the six concentration levels. The IC50 value was
obtained from the dose-response curve, which corresponds to the
concentration of XNT causing 50% decrease in cell growth.
2.6. NBD cholesterol uptake assay
The ﬂuorescent analogue, 22-(N-(7 nitrobenz-2-oxa-1,3-diazol-
4-yl)amino)-23,24-bisnor-5-cholen-3b-ol (NBD cholesterol;
Cayman) is a good indicator for in vitro and in vivo cholesterol
uptake [22]. The method was carried out according to manufac-
turer's instruction (Cayman Chemical Company, USA). In brief,
HT29 colon cells were cultured in 96-well black plate at
10,000 cells/well overnight prior to treatment. The cells were then
treated with 100 mL medium containing 20 mg/mL NBD cholesterol
with XNT (3.75, 7.5 and 15 mg/mL), U-18666A (positive control) or
vehicle control (DMSO) for 48 h. The plate was centrifuged for
5 min at 400g at room temperature. The supernatant was carefully
removed and 100 mL assay buffer was added. The ﬂuorescence was
analyzed at excitation and emissionwavelengths, lex¼ 485 nm and
lem ¼ 535 nm, respectively.
2.7. Oil red O staining
Oil red O (ORO) staining is used to elucidate the inhibitory effect
of lipid accumulation in adipocytes [20,23]. ORO-stained cells were
observed and measured as previously described [9] with slight
modiﬁcation. In brief, vehicle control (0.1% DMSO), positive control
(quercetin) and XNT (0.78e25 mg/mL) was added to differentiating
and maintenance medium every three days until day 15. Then, the
medium was carefully removed and the cells were ﬁxed with
100 mL of 10% formalin in PBS (pH 7.4) for 30 min at room tem-
perature. Cells were washed once with distilled water and then
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Then the wells were washed once with distilled water and photo-
graphed under a microscope CKX31 (Olympus Corporation, Japan)
at 10 magniﬁcation. ORO dye retained in the cells was measured
by eluting with 100 mL isopropanol, shaken for 20 min and read at
492 nm.
2.8. Statistical analysis
Statistical Package for the Social Sciences (SPSS) software
version 22.0 was used for statistical analysis [9]. The results were
shown as mean ± SEM. All data were calculated from three inde-
pendent experiments. Statistical signiﬁcance was established by
one-way analysis of variance (ANOVA) followed by post hoc Dun-
can test and Games-Howell test, where p < 0.05, p < 0.01 and
p < 0.001 were considered statistically signiﬁcant.
3. Results and discussion
Effective isolation of pure bioactive compound is critical, espe-
cially when the target compound exists in a very small amount
within a fraction. XNT is a sesquiterpenic phenol with a prenylic
chain attached to C-5 [24]. Based on Fig. 1, 1H NMR and 13C NMR
analysis conﬁrmed the isolated compound was XNT (light
brownish oil), whilst GC-MS analysis showed a major single peak of
2 with 98.3% peak area in TIC proﬁle (Fig. 1A). Its molecular formula
was determined by high resolution mass spectrum corresponding
to the formula C15H22O (CAS#30199-26-9). According to 1H NMR
(CDCl3, 300 MHz), the presence of phenyl (Ph) group was clearly
seen from signals at d(ppm) 1.196 (d, 3H, eCH3-9), 1.523e1.578 (m,
2 H, eCH2-10), 1.665 (s, 6H, eC(CH3)2-14,15), 1.858e1.887 (m, 2H,
eCH2-11), 2.208 (s, 3H, eCH3-7), 2.568e2.639 (m, 1, eCH-8),
5.064e5.092 (m, 1H, eCH]C-12), 6.603 (s, 1H, Ph), 6.669 (dd, 1 H,
Ph), 7.018 (d, 1H, Ph) (Fig. 1B).
On the other hand, 13C NMR spectral (CDCl3, 75 MHz) directly
indicated the carbon skeleton of XNT molecule by identifying the
number of nonequivalent carbons and types of carbon atoms
(Fig. 1C). XNT comprised of one phenolic hydroxyl group ortho to
the methyl group. Overall, centrifugal TLC demonstrated 41.2% (w/
w) yield of XNT at 98.3% purity. The results indicated that centrif-
ugal TLC may be an alternative method to purify XNT. Centrifugal
TLC is highly effective because it can yield a highly pure compoundFig. 1. Identiﬁcation of puriﬁed XNT from centrifugal TLC. GC-MS showed the purity of XNT
NMR spectral (C).from a small amount of sample. During the operation of centrifugal
TLC, we can easily observe the spherical bands of the separated
compounds by UV 254/365 lamps throughout centrifugal radial
separation. At the same time, immediate separation is achieved by
accelerated centrifugal force of the spinning rotor moving the sol-
vents through the adsorbent layer [25].
Our recent review summarized that XNT not only inhibited the
proliferation of various cancer cells but also some normal cells [17].
MTT assay was based on the principle of the formation of coloured
formazan product from the reduction of MTT by the mitochondria
in viable cells [26]. In this study, XNT signiﬁcantly inhibited the
growth towards HT29 colon cells at 25 mg/mL (66.44 ± 2.44%)
(p < 0.05) and 50 mg/mL (12.01 ± 1.9%) (p < 0.01). On the other
hand, there was only 5.9 ± 0.58% of 3T3-L1 adipocytes survived,
which was signiﬁcantly lower than 3T3-L1 preadipocytes
(81.31 ± 0.55%) (p < 0.001). Therefore, IC50 values were
30.81 ± 0.78 mg/mL and 35.07 ± 0.24 mg/mL in HT29 colon cells and
3T3-L1 adipocytes, respectively but not detectable in preadipocytes
(Fig. 2).
To our knowledge, this is the ﬁrst report demonstrated that XNT
inhibited the cholesterol uptake in HT29 colon cells. Since intestine
is one of the main tissues involved in the cholesterol uptake and
metabolism, HT29 human colon cells are used in the antilipidemic
studies. They are extensively used as an in vitro model for the in-
testinal epithelium [27] due to their imitation of normal intestinal
ontogenesis and epithelial crypt-to-villus migration [28]. Because
of their numerous characteristics of enterocytes, they have been
used to study the intestinal drug and nutrient transport and
metabolism including in vitro transport of lipids [29]. On the other
hand, NBD cholesterol is a ﬂuorescent analogue of cholesterol,
which has been reported to have same properties as native
cholesterol in terms of transport in vitro and in vivo [30e32]. The
results showed that XNT dose-dependently inhibited NBD-
cholesterol uptake by HT29 colon cells, where a maximal inhibi-
tionwas shown in 15 mg/mL XNT (27 ± 3.14%) (Fig. 3). The inhibition
was not signiﬁcantly different with positive control, U-18666A
(30 ± 3.83%).
We postulate that 16 ± 1.13% to 27 ± 3.14% of reduction of NBD
cholesterol absorption by XNT-treated HT29 colon cells might be
due to its ability to suppress the cholesterol uptake through inhi-
bition of Niemann-Pick C1-like 1 cholesterol transporter. Another
possible explanation of XNT in cholesterol inhibition was itsat 98.3% abundance (A). The structure was identiﬁed by 1H NMR spectral (B) and 13C
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impeding NBD-cholesterol uptake in HT29 cells. Previous studies
postulated that the phenolic hydroxyl group on the bisabolene
skeleton of XNT might chelate Cu2þ, thus inhibited low-density-
lipoprotein (LDL) oxidation and free radicals production [16].
Since XNT may act as a potent phytoestrogen, we suggest that XNT
may possess the characteristics of phytosterol by displacing
cholesterol from the micelles. This in turns decreased the intestinal
absorption of cholesterol.
On the other hand, antiproliferative activity of XNT in 3T3-L1
preadipocytes and adipocytes may provide a new insight into the
role of XNT to suppress adipocyte development. Seeing that inhi-
bition of preadipocyte proliferation is one of the mechanisms of
antiobesity [33], XNT treatment (50 mg/mL) that reduced
18.7 ± 0.55% of growth of dividing preadipocytes may decrease the
number of differentiated adipocytes (Fig. 2). As preadipocytes can
divide throughout the life, antiproliferative activity towards pre-
adipocytes can decrease the mass of adipose tissue. Besides,Fig. 3. NBD cholesterol uptake in HT29 colon cells. The cells were exposed to 3.75, 7.5 and
relative to vehicle control (0.1% DMSO). *p < 0.05 was considered statistically signiﬁcant co
Fig. 2. Dose response curve of XNT in HT29 colon cells, 3T3-L1 preadipocytes and adipocyt
and 50 mg/mL) for 48 h. The percentage of growth in relative to vehicle control (0.1% DMSO) w
statistically signiﬁcant compared to control.reducing the number of adipocytes may reduce the fat accumula-
tion in the cells. Since high dose of XNT (35 mg/mL) suppressed 50%
of the growth of 3T3-L1 adipocytes (Fig. 2), we suggest that cell
deathmay be due to apoptosis. As mentioned in recent review, XNT
induced cell death in numerous types of cancer cells by apoptosis
[17]. We postulate that antiproliferative effect of XNT was signiﬁ-
cantly higher in non-dividing stage of 3T3-L1 cells due to the sus-
ceptibility of quiescent cells and terminally-differentiated cells
towards its apoptotic effect. Thus, we postulate that reducing the
number of preadipocytes and adipocytes by XNT could reduce se-
vere obesity.
To determine whether XNT affects the intracellular lipid for-
mation in 3T3-L1 adipocytes, ORO staining was used as a good in-
dicator to evaluate the degree of differentiation. Differentiated
adipocytes have enlarged lipid droplets which can be stained with
fat soluble dye, ORO [34]. The color intensity is directly propor-
tional to the degree of differentiation and triglyceride accumulation
[35,36]. It is obvious that XNT dose-dependently reduced lipid15 mg/mL of XNT for 48 h. The percentage of NBD cholesterol uptake was calculated in
mpared to control.
es. The cells were exposed to various concentrations of XNT (0, 1.56, 3.13, 6.25, 12.5, 25
as determined by MTT method. *p < 0.05, **p < 0.01 and ***p < 0.001 were considered
Fig. 4. Intracellular lipid stained with ORO in 3T3-L1 mature adipocytes. Adipocytes were exposed to various concentrations of XNT for 15 days. Quercetin was used as a positive
control. The red color indicated the formation of lipid droplets inside the cells. ORO was then quantiﬁed at 492 nm. **p < 0.01 was considered statistically signiﬁcant. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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but 25 mg/mL did not exert any effect (Fig. 4). Concentration as low
as 3.125 mg/mL XNT signiﬁcantly inhibited fat deposition for
15.66 ± 2.54% (p < 0.01), whilst a maximal inhibition was shown at
12.5 mg/mL (36.13 ± 2.1%). Quercetin was used as a positive control
because it has been known as an inhibitor of adipogenesis [4]. Since
XNT had a higher ORO reduction of 10.44% than quercetin at 15 mg/
mL, we postulate that XNT is more potent than quercetin. Thus,
targeting the adipocyte life cycle by XNT could be an advantage
towards prevention and treatment of obesity.
Overall, our results demonstrated that XNT inhibited cholesterol
uptake, reduced lipid formation, decreased preadipocyte and
adipocyte number. Hence, we propose that these combination ef-
fects may be beneﬁcial in atherosclerosis. Further studies are being
conducted to identify its mechanisms of action.
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